Bunge S.A., a leader in oilseed processing, faces operational challenges but offers long-term upside, making it an attractive investment at current valuations. Despite a volatile earnings environment, Bunge's BBB+ rating, 3.5% yield, and strategic moves, including the Viterra merger, enhance its investment appeal. The company's valuation is compelling, trading below sector averages, with a potential upside of over 30% and a price target of $125/share by 2026.
Archer-Daniels-Midland's valuation is low, with a forward P/E of 11.7X and a 3.7% dividend yield, but faces weak YoY performance and accounting investigations. Rising labor and energy costs, regulatory scrutiny, and shifting consumer trends weigh on ADM's profitability and long-term prospects. ADM's nutrition segment is under investigation, leading to restated financials, a significant decline in operating profit earlier this year, and delayed Q3 results.
Bunge Global SA (NYSE:BG ) Q3 2024 Earnings Conference Call October 30, 2024 8:00 AM ET Company Participants Greg Heckman - Chief Executive Officer John Neppl - Chief Financial Officer Ruth Ann Wisener - Vice President, Investor Relations Conference Call Participants Andrew Strelzik - BMO Capital Markets Salvatore Tiano - Bank of America Tom Palmer - Citi Manav Gupta - UBS Heather Jones - Heather Jones Research Stephen Hayes - Morgan Stanley Ben Theurer - Barclays Operator Good day and welcome to the Bunge Global SA third quarter 2024 earnings release and conference call. All participants will be in listen-only mode.
While the top- and bottom-line numbers for Bunge Global (BG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Bunge Global (BG) came out with quarterly earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.99 per share a year ago.
Bunge Global (BG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I recommend a scale-down buying approach for Bunge Global SA shares, especially during price weakness, due to its strong fundamentals and attractive dividend yield. BG shares have declined 14.8% since mid-May 2024, nearing the bottom of their $80-$120 range, with earnings expected at the end of October. Lower grain, oilseed, and ethanol prices have pressured BG's earnings, but higher sugar and soybean crush spreads offer some relief.
The near-term outlook for the Zacks Agriculture - Products industry is uncertain due to low commodity prices and inflated costs. Investors should watch BG, WFG, HYFM and RKDA, which are braving the industry headwinds.
BG completes the sale of its 50% interest in the sugar and bioenergy joint venture to its partner, BP, as it was not core to its long-term strategy.
The S&P 500's strong performance and high valuations make finding bargains challenging. Many stocks trade at elevated P/E ratios, complicating value-driven strategies. Despite a pricey market, I've found three undervalued stocks, each with dividend yields, secular growth trends, and potential for significant price appreciation. These picks are at least 40% undervalued, offering long-term tailwinds and solid business models. They present unique opportunities in an otherwise expensive market.
Investors need to pay close attention to Bunge Global (BG) stock based on the movements in the options market lately.
Sometimes, even the most boring stocks hold big potential. Look at plant-based food stocks, for example.